Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Autoimmune Disorders

Free Subscription 24.11.2025 1 Am J Kidney Dis 2 BMC Neurol 2 Brain 8 Diabet Med 3 Intern Med 1 J Autoimmun 6 J Clin Endocrinol Metab 2 J Neuroimmunol 8 J Neurol 6 J Rheumatol 3 Kidney Int 1 Lancet 1 Nat Rev Neurol 1 Neurology 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. DESAI NB, Gashti C, Whittier WL
   "A Change is Gonna Come" to Treatment of Lupus Nephritis: A Review.
   Am J Kidney Dis. 2025 Nov 12:S0272-6386(25)01144.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. JAKI R, Al-Frejat Z, Bitar Z
   Tumefactive demyelinating lesions: a case report and literature review.
   BMC Neurol. 2025;25:475.
   PubMed         Abstract available
   
   
3. TOTUK O, Turkkol M, Yadi F, Gudek HC, et al
   Sexual dysfunction in multiple sclerosis: prevalence, risk factors, and impact on quality of life in a large cohort study.
   BMC Neurol. 2025;25:468.
   PubMed         Abstract available
   
   

   
   Brain

4. FEINSTEIN A, Bar-Or A, Benedict RHB, Filippi M, et al
   Is multiple sclerosis-related depression different from depression in general? The data for and against.
   Brain. 2025 Sep 9:awaf319. doi: 10.1093.
   PubMed         Abstract available
   
   
5. MACESKI AM, Benkert P, Einsiedler M, Schaedelin S, et al
   GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
   Brain. 2025 Nov 14:awaf433. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

6. JESPERSEN LN, Schonning SH, Truelsen MF, Grabowski D, et al
   Facilitating dialogue with adolescents with diabetes: Development of 'The Adolescent Mirror'-A research-based dialogue tool.
   Diabet Med. 2025 Oct 3:e70144. doi: 10.1111/dme.70144.
   PubMed         Abstract available
   
   
7. LAWTON J, Kyle CJ, Chambers TJG, Steven L, et al
   What training and support do people need to make optimal use of automated insulin delivery systems: Interview study.
   Diabet Med. 2025;42:e70153.
   PubMed         Abstract available
   
   
8. MANJELIEVSKAIA J, Shah VN, Carlson AL, Isaacs D, et al
   Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021.
   Diabet Med. 2025;42:e70147.
   PubMed         Abstract available
   
   
9. LITCHMAN ML, Berg CA, Porter M, Campbell MS, et al
   Family member involvement when multiple family members have type 1 diabetes.
   Diabet Med. 2025 Oct 6:e70145. doi: 10.1111/dme.70145.
   PubMed         Abstract available
   
   
10. PEMBERTON JS, Russon CL, Pulsford RM, Metcalf BS, et al
    Glucose-lowering effects of physical activity in type 1 diabetes: A causal modelling and matched-pair analysis approach.
    Diabet Med. 2025 Oct 8:e70146. doi: 10.1111/dme.70146.
    PubMed         Abstract available
    
    
11. LOMBARDI K, Paciente R, Coombs S, Hanna N, et al
    A randomised trial of a trauma-informed well-being program to promote mental health in adolescents with type 1 diabetes: Study protocol.
    Diabet Med. 2025 Oct 10:e70148. doi: 10.1111/dme.70148.
    PubMed         Abstract available
    
    
12. LAURENZI A, Edd SN, Adolfsson P, Di Piazza F, et al
    Insights into the effective use of the Smart MDI system: Data from the first 1852 type 1 diabetes users.
    Diabet Med. 2025 Oct 13:e70161. doi: 10.1111/dme.70161.
    PubMed         Abstract available
    
    
13. ELLIOTT J, Hopley C, Riley D, Dodd O, et al
    Assessment of the added value of a tubeless pump: A time trade-off (TTO) study for utility elicitation of insulin delivery systems in type 1 diabetes mellitus (T1D).
    Diabet Med. 2025 Oct 30:e70156. doi: 10.1111/dme.70156.
    PubMed         Abstract available
    
    

    
    Intern Med

14. YAMAMOTO M, Dembo T, Oji S, Kaida K, et al
    A Diagnostic Approach to VZV Vasculopathy Using MR Vessel Wall Imaging.
    Intern Med. 2025;64:3298-3301.
    PubMed         Abstract available
    
    
15. OKA T, Tsuji Y, Sakai T, Mori M, et al
    Intervascular Large B-cell Lymphoma with Severe Anemia and a High-titer of Cold Agglutinin.
    Intern Med. 2025;64:3279-3283.
    PubMed         Abstract available
    
    
16. NAGASHIMA T, Yabe H, Sekiguchi Y
    G-CSF-induced Aortitis Mimicking TIPIC Syndrome.
    Intern Med. 2025;64:3302-3305.
    PubMed         Abstract available
    
    

    
    J Autoimmun

17. HASSLER S, Aste J, Berenbaum F, Rosenzwajg M, et al
    Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis.
    J Autoimmun. 2025;157:103502.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

18. DE MEULEMEESTER J, Valgaerts L, Massa G, Gies I, et al
    Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 May 7:dgaf265. doi: 10.1210.
    PubMed         Abstract available
    
    
19. BRANDT IAG, Vestergaard P, Harslof T, Juhl CB, et al
    Association between Muscle status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-Sectional Study.
    J Clin Endocrinol Metab. 2025 Apr 23:dgaf245. doi: 10.1210.
    PubMed         Abstract available
    
    
20. CHEN C, Yu L, Lan MS
    Modulation of Functional Activity of INS-VNTR Class I Haplotype Derived from Type 1 Diabetic Patients.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf243. doi: 10.1210.
    PubMed         Abstract available
    
    
21. ZHANG M, Qi X, Zhou X, Liu Y, et al
    A preclinical state of Graves' ophthalmopathy characterized by hypoxia of T-cells identified via multi-omics analysis.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf230. doi: 10.1210.
    PubMed         Abstract available
    
    
22. KVIST AV, Frost M, Burden AM, Vestergaard P, et al
    Direct healthcare cost of fractures in patients with type 1 diabetes: a population-based cohort study in Denmark.
    J Clin Endocrinol Metab. 2025 Apr 10:dgaf199. doi: 10.1210.
    PubMed         Abstract available
    
    
23. MONTASER E, Abad SE, Shah VN
    Changes in A1C versus GMI Across Glycemic Categories in Clinical Trials of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf211. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

24. GOLGE BF, Sarikaya C, Bingol CA, Aktekin B, et al
    Autoimmune encephalitis following bevacizumab therapy in ovarian carcinoma: A case report and review.
    J Neuroimmunol. 2025;410:578804.
    PubMed         Abstract available
    
    
25. CERRONI S, Hoshina Y, Glenn T, Goel N, et al
    Characteristics and prognosis of PCA-1 (anti-Yo) autoimmunity and the utility of the Brief Ataxia Rating Scale in a seropositive cerebellar ataxia cohort.
    J Neuroimmunol. 2025;410:578812.
    PubMed         Abstract available
    
    

    
    J Neurol

26. YANG X, Li F, Zhe J, Zhang Z, et al
    Single-cell RNA sequencing of cerebrospinal fluid immune cells in relapsing-remitting multiple sclerosis: insights into cellular composition and immune dynamics.
    J Neurol. 2025;272:778.
    PubMed         Abstract available
    
    
27. TEDONE N, Grosselle M, Portaccio E, Amato MP, et al
    The brief repeatable battery of neuropsychological test (BRB-N) version B: update of Italian normative data.
    J Neurol. 2025;272:776.
    PubMed         Abstract available
    
    
28. MONSCHEIN T, Untersteiner H, Ponleitner M, Krajnc N, et al
    Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR).
    J Neurol. 2025;272:774.
    PubMed         Abstract available
    
    
29. WANG R, Wang X, Shi Z, Kong L, et al
    Severe attacks and worse prognosis in patients with late-onset neuromyelitis optica spectrum disorder highlight the need for early highly effective treatment.
    J Neurol. 2025;272:771.
    PubMed         Abstract available
    
    
30. STEINER OL, Angela C, Krasivskaya E, Klostermann F, et al
    Cognitive impairment in chronic inflammatory demyelinating polyneuropathy.
    J Neurol. 2025;272:769.
    PubMed         Abstract available
    
    
31. MESSINA C
    The overlooked side of myasthenia gravis: the non-motor manifestations-a comprehensive review.
    J Neurol. 2025;272:764.
    PubMed         Abstract available
    
    
32. MARTIRE MS, Gattuso I, Vezzulli P, Guerrieri S, et al
    Unveiling a silent threat: slowly expanding spinal cord lesion linked to clinical worsening in multiple sclerosis: a case report.
    J Neurol. 2025;272:773.
    PubMed        
    
    
33. LADEIRA F, Nobrega C, Cerqueira J
    Correction: Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study.
    J Neurol. 2025;272:768.
    PubMed        
    
    

    
    J Rheumatol

34. QI W, Yuen SY, Popescu ML, Yang R, et al
    The Burden of Enthesitis, Inflammatory Arthritis and Tenosynovitis on Musculoskeletal Ultrasound in Systemic Lupus Erythematous: A Scoping Review.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0684. doi: 10.3899/jrheum.2025-0684.
    PubMed         Abstract available
    
    
35. PARPERIS K, Bertsias G, Lampi M, Constantinou M, et al
    Time trends in acute coronary syndrome hospitalizations and outcomes in patients with Systemic Lupus Erythematosus: A US inpatient cohort analysis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0627. doi: 10.3899/jrheum.2025-0627.
    PubMed         Abstract available
    
    
36. PATEL H, Stoots S, Von Feldt J, Baker JF, et al
    Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0465. doi: 10.3899/jrheum.2025-0465.
    PubMed         Abstract available
    
    
37. O'CONNOR SK, Devarajan P, Liu J, Maldonado MA, et al
    The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0504. doi: 10.3899/jrheum.2025-0504.
    PubMed         Abstract available
    
    
38. FLATMAN LK, Bernatsky S, Berard A, Vinet E, et al
    Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
    J Rheumatol. 2025;52:1159-1165.
    PubMed         Abstract available
    
    
39. KILBAS G, Ayduran S, Sener S, Coskuner T, et al
    Results of a Nationwide Multicenter Study in Childhood Sjogren Disease.
    J Rheumatol. 2025;52:1141-1150.
    PubMed         Abstract available
    
    

    
    Kidney Int

40. GLASSOCK RJ
    Berger disease redux.
    Kidney Int. 2025;108:999-1001.
    PubMed         Abstract available
    
    
41. FLOEGE J, Bernier-Jean A, Barratt J, Rovin B, et al
    Corrigendum to "Treatment of patients with IgA nephropathy: a call for a new paradigm." Kidney International 2025;107:640-651.
    Kidney Int. 2025;108:1197-1198.
    PubMed        
    
    
42. TAKAHASHI-KOBAYASHI M, Usui J
    THSD7A-positive membranous nephropathy detected by mass spectrometry despite negative immunofluorescence.
    Kidney Int. 2025;108:1191-1192.
    PubMed        
    
    

    
    Lancet

43. GAO J, Li M, Sun M, Yu Y, et al
    Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China.
    Lancet. 2025 Nov 12:S0140-6736(25)01671-X. doi: 10.1016/S0140-6736(25)01671.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

44. BECKER J, Pitombeira MS, Rojas JI
    Epidemiology and characteristics of multiple sclerosis in Latin America.
    Nat Rev Neurol. 2025 Nov 17. doi: 10.1038/s41582-025-01160.
    PubMed         Abstract available
    
    

    
    Neurology

45. HUANG X, Yu ZH, Cui Y, Zhang H, et al
    Outcomes in Relation to the Age at Onset in Patients With Myasthenia Gravis.
    Neurology. 2025;105:e214428.
    PubMed         Abstract available
    
    

    
    PLoS One

46. SURESHKUMAR A, Simpson R, Bayley M, Kastner M, et al
    The use of implementation strategies to promote the uptake of psychological therapies among people with multiple sclerosis: A scoping review protocol.
    PLoS One. 2025;20:e0337105.
    PubMed         Abstract available
    
    
47. TABATABAEE S, Eissazade N, Mirzaasgari Z, Tabatabaee SM, et al
    Trans-orbital sonography of the optic nerve in multiple sclerosis.
    PLoS One. 2025;20:e0336564.
    PubMed         Abstract available
    
    
48. SALMAN F, Bergsland N, Dwyer MG, Reeves JA, et al
    Impact of processing and analysis methodology on thalamic susceptibility assessment in multiple sclerosis.
    PLoS One. 2025;20:e0332478.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.